161 related articles for article (PubMed ID: 18292522)
1. Rat CD4+CD8+ macrophages kill tumor cells through an NKG2D- and granzyme/perforin-dependent mechanism.
Baba T; Iwasaki S; Maruoka T; Suzuki A; Tomaru U; Ikeda H; Yoshiki T; Kasahara M; Ishizu A
J Immunol; 2008 Mar; 180(5):2999-3006. PubMed ID: 18292522
[TBL] [Abstract][Full Text] [Related]
2. CD4+/CD8+ macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype.
Baba T; Ishizu A; Iwasaki S; Suzuki A; Tomaru U; Ikeda H; Yoshiki T; Kasahara M
Blood; 2006 Mar; 107(5):2004-12. PubMed ID: 16269616
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
Westwood JA; Kelly JM; Tanner JE; Kershaw MH; Smyth MJ; Hayakawa Y
J Immunol; 2004 Jan; 172(2):757-61. PubMed ID: 14707044
[TBL] [Abstract][Full Text] [Related]
5. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
Abdool K; Cretney E; Brooks AD; Kelly JM; Swann J; Shanker A; Bere EW; Yokoyama WM; Ortaldo JR; Smyth MJ; Sayers TJ
J Immunol; 2006 Aug; 177(4):2575-83. PubMed ID: 16888019
[TBL] [Abstract][Full Text] [Related]
6. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway.
Zhang ZX; Ma Y; Wang H; Arp J; Jiang J; Huang X; He KM; Garcia B; Madrenas J; Zhong R
J Immunol; 2006 Nov; 177(10):6920-9. PubMed ID: 17082607
[TBL] [Abstract][Full Text] [Related]
7. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway.
Vermijlen D; Luo D; Froelich CJ; Medema JP; Kummer JA; Willems E; Braet F; Wisse E
J Leukoc Biol; 2002 Oct; 72(4):668-76. PubMed ID: 12377935
[TBL] [Abstract][Full Text] [Related]
8. The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation.
Srivastava RM; Varalakshmi C; Khar A
J Immunol; 2008 Jan; 180(2):1117-30. PubMed ID: 18178852
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.
Hodge G; Barnawi J; Jurisevic C; Moffat D; Holmes M; Reynolds PN; Jersmann H; Hodge S
Clin Exp Immunol; 2014 Oct; 178(1):79-85. PubMed ID: 24894428
[TBL] [Abstract][Full Text] [Related]
10. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D.
Savithri B; Khar A
Eur J Immunol; 2006 Jan; 36(1):107-17. PubMed ID: 16323246
[TBL] [Abstract][Full Text] [Related]
11. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH
Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
[TBL] [Abstract][Full Text] [Related]
13. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
14. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells.
Rabinovich BA; Li J; Shannon J; Hurren R; Chalupny J; Cosman D; Miller RG
J Immunol; 2003 Apr; 170(7):3572-6. PubMed ID: 12646619
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides.
Grobárová V; Benson V; Rozbeský D; Novák P; Cerný J
Immunol Lett; 2013; 156(1-2):110-7. PubMed ID: 24076118
[TBL] [Abstract][Full Text] [Related]
16. Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.
Kurumagawa T; Seki S; Kobayashi H; Koike Y; Kanoh S; Hiraide H; Motoyoshi K
Clin Exp Immunol; 2003 Sep; 133(3):438-47. PubMed ID: 12930372
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
[TBL] [Abstract][Full Text] [Related]
18. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.
Smyth MJ; Swann J; Kelly JM; Cretney E; Yokoyama WM; Diefenbach A; Sayers TJ; Hayakawa Y
J Exp Med; 2004 Nov; 200(10):1325-35. PubMed ID: 15545356
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells, macrophages, NK and CD8
Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA
Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
